MNKD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MNKD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
MannKind's purchase of property, plant, equipment for the three months ended in Mar. 2024 was $-2.4 Mil. It means MannKind spent $2.4 Mil on purchasing property, plant, equipment. MannKind's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was $-36.5Mil.
Compared with last quarter ($-5.9 Mil in Dec. 2023 ), MannKind spent less money on purchasing property, plant, equipment in Mar. 2024 ($-2.4 Mil).
The historical data trend for MannKind's Purchase Of Property, Plant, Equipment can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MannKind Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Purchase Of Property, Plant, Equipment | Get a 7-Day Free Trial |
![]() |
![]() |
-2.57 | -0.80 | -11.47 | -7.59 | -42.44 |
MannKind Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Purchase Of Property, Plant, Equipment | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-8.31 | -16.87 | -11.39 | -5.87 | -2.41 |
The amount used to purchase PPE.
Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of MannKind's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Castagna | officer: Chief Commercial Officer | 25134 RYE CANYON LOOP, SUITE 300, VALENCIA CA 91355 |
David Thomson | officer: VP & Assoc General Counsel | 28903 NORTH AVENUE PAINE, VALENCIA CA 91355 |
Steven B. Binder | officer: Chief Financial Officer | 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362 |
Burkhard Blank | officer: EVP Chief Medical Officer | C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502 |
Lauren M Sabella | officer: EVP Chief Operating Officer | C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502 |
Sanjay R Singh | officer: EVP Technical Operations | 1 CASPER STREET, DANBURY CT 06810 |
Alejandro Galindo | officer: Chief Commercial Officer | 30930 RUSSELL RANCH RD, STE 300, WESTLAKE VILLAGE CA 91362 |
Stuart A Tross | officer: Corp VP, Chief People Officer | ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Anthony C Hooper | director | AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Jennifer Grancio | director | 30930 RUSSELL RANCH ROAD SUITE 300, WESTLAKE VILLAGE CA 91362 |
Christine Mundkur | director | |
Sabrina Kay | director | 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362 |
David M Kendall | officer: Chief Medical Officer | 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362 |
Patrick Mccauley | officer: Chief Commercial Officer | 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362 |
Barton Courtney | officer: Chief Compliance Officer | 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362 |
From GuruFocus
By GlobeNewswire GlobeNewswire • 06-11-2023
By GuruFocus Research • 07-05-2023
By Marketwired • 09-05-2023
By Marketwired • 07-31-2023
By Value_Insider Value_Insider • 11-01-2022
By sperokesalga sperokesalga • 06-11-2023
By Marketwired • 10-30-2023
By Marketwired • 08-01-2023
By Ds*** Ds*** • 09-01-2022
By sperokesalga sperokesalga • 05-24-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.